Europium activated gadolinium sulfide nanoparticles
In the present work, we report the synthesis and characterization of Eu 3+ doped Gd 2 S 3 nanoparticles, a potential candidate for T 1 -weighted MRI contrast agents and molecular markers. Eu 3+ doped Gd 2(1− x ) S 3 :Eu x ( x = 0.0, 0.02, 0.04 and 0.06) were synthesized by a chemical route by varyin...
Gespeichert in:
Veröffentlicht in: | RSC advances 2016-01, Vol.6 (11), p.18523-18529 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In the present work, we report the synthesis and characterization of Eu
3+
doped Gd
2
S
3
nanoparticles, a potential candidate for
T
1
-weighted MRI contrast agents and molecular markers. Eu
3+
doped Gd
2(1−
x
)
S
3
:Eu
x
(
x
= 0.0, 0.02, 0.04 and 0.06) were synthesized by a chemical route by varying the Eu concentration. X-ray diffraction and scanning electron microscopy were performed to extract the information about structure and surface morphology of prepared nanoparticles, respectively. The oxidation state of the Eu ions was elucidated from X-ray absorption near edge structure (XANES) spectra, which indicate the presence of only Eu
3+
ions without any signature of Eu
2+
ions. 120 MeV Ag
9+
ions were used for ionoluminescence (IL) measurements to study the optical properties. The IL results show that the luminescence intensity increases with increasing Eu doping and no saturation or degradation of the luminescence were observed for the as-prepared nanoparticles. The nanoparticles doped with 2 and 4% Eu showed an increase in the IL intensity initially before decreasing to saturation at higher fluences. On the other hand, IL intensity from 6% doped samples decreased exponentially and saturated at higher fluences.
For the first time, the ionoluminescence (IL) properties of Eu
3+
doped Gd
2
S
3
nanoparticles (a potential candidate for MRI contrast agents) are reported. |
---|---|
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/c6ra17413b |